• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在重症监护病房中血栓性微血管病患者的诊断评分表现:一项单中心研究。

Performance of Diagnostic Scores in Thrombotic Microangiopathy Patients in the Intensive Care Unit: A Monocentric Study.

机构信息

Service de Médecine Intensive-Réanimation, Hôpital Saint-Louis, APHP, Paris, France.

UFR Médecine, Université de Paris, Paris, France.

出版信息

Thromb Haemost. 2021 Nov;121(11):1427-1434. doi: 10.1055/a-1378-3804. Epub 2021 Mar 11.

DOI:10.1055/a-1378-3804
PMID:33512705
Abstract

Early thrombotic thrombocytopenic purpura (TTP) recognition is critical as this disease is almost always lethal if not treated promptly with therapeutic plasma exchanges. Currently, as ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) activity is not widely available in emergency, scores have been developed to help differentiating TTP from other thrombotic microangiopathies (TMAs). The aim of this work was to study the accuracy of these diagnostic scores in the intensive care unit (ICU) setting. Performance of both Coppo and PLASMIC scores was studied in a cohort of adult TMA patients requiring admission to one university hospital ICU from 2006 to 2017. Receiver operating characteristic (ROC) curves were established, and confidence intervals of the area under the curve (AUC) were determined. Multivariate logistic regression analysis was performed to identify parameters specifically associated with TTP, to compare diagnostic scores and to elaborate more accurate diagnostic models. During the study period, 154 TMA patients required ICU admission, including 99 (64.2%) TTP and 55 (35.7%) non-TTP patients. AUC under the ROC curve in predicting TTP was 0.86 (95% confidence interval [CI]: 0.81-0.92) for the Coppo score, 0.67 (95% CI: 0.58-0.76) for the PLASMIC score, and 0.86 (95% CI: 0.81-0.92) for platelet count alone. Platelet count ≤20 G/L, determined as the best cut-off rate for thrombocytopenia, performed similarly to the Coppo score and better than the PLASMIC score to differentiate TTP from non-TTP patients, both using AUC ROC curve and logistic regression. In a monocentric cohort of TMA patients requiring ICU admission, the PLASMIC score had limited performance for the diagnosis of TTP. The performance of the Coppo score was good but similar to a single highly discriminant item: platelet count ≤20 G/L at admission.

摘要

早期血栓性血小板减少性紫癜(TTP)的识别至关重要,因为如果不及时进行治疗性血浆置换,这种疾病几乎总是致命的。目前,由于 ADAMTS13(一种具有血小板反应蛋白 1 型基序的解整合素金属蛋白酶 13)活性在急诊中尚未广泛应用,因此已经开发了评分来帮助区分 TTP 与其他血栓性微血管病(TMA)。本研究旨在研究这些诊断评分在重症监护病房(ICU)环境中的准确性。在 2006 年至 2017 年间,需要入住一所大学医院 ICU 的成人 TMA 患者队列中,研究了 Coppo 和 PLASMIC 评分的性能。建立了受试者工作特征(ROC)曲线,并确定了曲线下面积(AUC)的置信区间。进行了多变量逻辑回归分析,以确定与 TTP 特别相关的参数,比较诊断评分并制定更准确的诊断模型。在研究期间,154 名 TMA 患者需要 ICU 入院,其中 99 名(64.2%)为 TTP,55 名(35.7%)为非 TTP 患者。Coppo 评分预测 TTP 的 ROC 曲线下 AUC 为 0.86(95%置信区间[CI]:0.81-0.92),PLASMIC 评分为 0.67(95%CI:0.58-0.76),血小板计数单独为 0.86(95%CI:0.81-0.92)。血小板计数≤20 G/L,确定为血小板减少症的最佳截断率,与 Coppo 评分一样,优于 PLASMIC 评分,用于区分 TTP 与非 TTP 患者,ROC 曲线和逻辑回归均如此。在需要 ICU 入院的 TMA 患者的单中心队列中,PLASMIC 评分对 TTP 的诊断性能有限。Coppo 评分的性能良好,但与单一高度鉴别项目相似:入院时血小板计数≤20 G/L。

相似文献

1
Performance of Diagnostic Scores in Thrombotic Microangiopathy Patients in the Intensive Care Unit: A Monocentric Study.在重症监护病房中血栓性微血管病患者的诊断评分表现:一项单中心研究。
Thromb Haemost. 2021 Nov;121(11):1427-1434. doi: 10.1055/a-1378-3804. Epub 2021 Mar 11.
2
Reduced sensitivity of PLASMIC and French scores for the diagnosis of thrombotic thrombocytopenic purpura in older individuals.PLASMIC 和 French 评分对老年患者血栓性血小板减少性紫癜诊断敏感性降低。
Transfusion. 2021 Jan;61(1):266-273. doi: 10.1111/trf.16188. Epub 2020 Nov 12.
3
The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry.ADAMTS13 在鉴别 TTP 与其他急性血栓性微血管病中的作用:来自英国 TTP 登记处的结果。
Br J Haematol. 2015 Dec;171(5):830-5. doi: 10.1111/bjh.13654. Epub 2015 Sep 11.
4
Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).ADAMTS13 在血栓性微血管病(包括血栓性血小板减少性紫癜[TTP])管理中的作用。
Br J Haematol. 2013 Nov;163(4):514-9. doi: 10.1111/bjh.12569. Epub 2013 Sep 20.
5
Indicators Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies in a Canadian Apheresis Referral Center.加拿大单采中心用于鉴别血栓性血小板减少性紫癜与其他血栓性微血管病的指标。
Am J Clin Pathol. 2021 Nov 8;156(6):1103-1112. doi: 10.1093/ajcp/aqab078.
6
A validation and modification of PLASMIC score by adjusting the criteria of mean corpuscular volume and international normalized ratio.通过调整平均红细胞体积和国际标准化比值的标准对 PLASMIC 评分进行验证和修正。
J Clin Apher. 2023 Oct;38(5):582-589. doi: 10.1002/jca.22068. Epub 2023 Jun 16.
7
Validation of PLASMIC score in a cohort of patients with suspected thrombotic microangiopathy in an academic medical centre.验证 PLASMIC 评分在学术医疗中心疑似血栓性微血管病患者队列中的应用。
Blood Transfus. 2023 Jul;21(4):345-349. doi: 10.2450/2022.0082-22. Epub 2022 Aug 9.
8
Performance Validation of Three Scoring Systems for the Prediction of Thrombotic Microangiopathy Due to Severe ADAMTS13 Deficiency and the Response to Therapeutic Plasma Exchange: First Study in Korea.三种评分系统对严重 ADAMTS13 缺乏导致的血栓性微血管病预测及治疗性血浆置换反应的性能验证:韩国的首次研究。
Ann Lab Med. 2023 Sep 1;43(5):485-492. doi: 10.3343/alm.2023.43.5.485. Epub 2023 Apr 21.
9
External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment.PLASMIC 评分的外部验证:用于血栓性血小板减少性紫癜诊断和治疗的临床预测工具。
J Thromb Haemost. 2018 Jan;16(1):164-169. doi: 10.1111/jth.13882. Epub 2017 Nov 16.
10
Evaluation of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies: Lessons learned from a 14-year retrospective study.血栓性血小板减少性紫癜和其他血栓性微血管病的评估:一项 14 年回顾性研究的经验教训。
Ther Apher Dial. 2023 Feb;27(1):136-145. doi: 10.1111/1744-9987.13864. Epub 2022 May 11.

引用本文的文献

1
Immune-mediated thrombotic thrombocytopenic purpura: don't miss the boat.免疫介导的血栓性血小板减少性紫癜:别错失良机。
Intensive Care Med. 2024 Feb;50(2):287-290. doi: 10.1007/s00134-023-07300-8. Epub 2024 Jan 9.
2
Severe Thrombotic Thrombocytopenic Purpura (TTP) with Organ Failure in Critically Ill Patients.危重症患者伴器官衰竭的严重血栓性血小板减少性紫癜(TTP)
J Clin Med. 2022 Feb 19;11(4):1103. doi: 10.3390/jcm11041103.